KOD compared with BCYC: revenue, margins and what each company keeps, and the suppliers and customers both name

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

BCYCBicycle Therapeutics PLC

Mkt capRevenueRevenue

Compare

KODKodiak Sciences Inc.

BCYCBicycle Therapeutics PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KOD

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+3.43%×0.35

May 8 '26±8.6%▼−6.11%×0.71

Q1 FY26±15.0%▲+12.30%×0.82

Q3 FY25±19.4%▲+3.39%×0.18

BCYC1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±22.5%▼−1.55%×0.07

= impliedKOD realized, solidBCYC realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

KODKodiak Sciences Inc.

100.68▲+0.28%· post 99.34

Mkt cap$6.2BRevenue—Revenue—

BCYCBicycle Therapeutics PLC

3.65▼−4.34%· post 3.65

ClosedOct 30 '26

Mkt cap$256.5MRevenue$34MQ3 FY26Revenue$73MFY25

Compare

ClosedOct 30 '26

KODKodiak Sciences Inc.

BCYCBicycle Therapeutics PLC

100.68▲+0.28%post 99.34

Price

3.65▼−4.34%post 3.65

$6.2B

Mkt cap

$256.5M

—

Revenue

$34MQ3 FY26

—

Revenue

$73MFY25

KOD100.68▲+0.28%vsBCYC3.65▼−4.34%ClosedOct 30 '26